Dietary Modulation Of Gut Microbiota In Overweight Individuals | 14858
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 1407

Journal of Obesity & Weight Loss Therapy received 1407 citations as per google scholar report

Journal of Obesity & Weight Loss Therapy peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • University of Bristol
Share This Page

Dietary modulation of gut microbiota in overweight individuals

2nd International Conference and Exhibition on Obesity & Weight Management

Jelena Vulevic

Accepted Abstracts: J Obes Weight Loss Ther

DOI: 10.4172/2165-7904.S1.012

Recent studies have shown that the gut microbiota varies in both its composition (e.g. reduced levels of bifidobacteria and increased levels of less desirable bacteria) and its metabolic activity in obese individuals compared with lean individuals. It seems that microbiota can modulate host energy homeostasis and adiposity through a number of different mechanisms, including harvesting energy from food, lipopolysaccharide (LPS)-induced chronic inflammation, modulation of tissue fatty acid composition and gut-derived-peptide secretion. Modulation of the gut microbiota by dietary means is the basis for the probiotic and prebiotic concepts. The majority of scientific data on prebiotic effects comes from studies with either inulin-type fructooligosaccharides (FOS) or galactooligosaccharides (GOS). The capacity of these prebiotics to selectively stimulate the growth of bifidobacteria, and in some cases lactobacilli, and elicit a significant change in the overall composition of the gut microbiota has been demonstrated repeatedly. With regard to obesity and related metabolic disorders, the majority of available data related to prebiotics comes from animal models and dietary supplementation with FOS. These studies suggest that prebiotics are able to regulate food intake and weight gain, glucose homeostasis, dyslipidemia, steatosis and hypertension. However, one recent study looked at the effect of a unique second generation prebiotic GOS and found significant positive effects on microbiota, immune response and metabolic syndrome markers in overweight individuals. This presentation will aim to summarise the ?obese microbiota?, its possible beneficial modulation through the use of prebiotics with the emphasis on the second generation prebiotic GOS.
Jelena Vulevic has a Ph.D. in gut microbiology with 13 years research experience in the area of functional food ingredients at the University of Reading, United Kingdom. She has supervised number of undergraduate and postgraduate (both M.Sc. and Ph.D.) students, lectured on the variety of courses and presented at various seminars and conferences. The topics included microbiota, prebiotics, probiotics, omega-3-fatty acids, flavonoids, medical nutrition, etc. Currently she is employed as Medical Liaison Manager at Clasado Ltd.